Action Observation Treatment (AOT) as a Rehabilitation Tool
NCT ID: NCT02235350
Last Updated: 2014-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2014-06-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of AOT Based on Virtual Reality in Stroke Rehabilitation.
NCT05163210
Action Observation Training for Upper Limb Recovery in Patients With Stroke
NCT04604171
Action Observation Theraphy in Severe Acquired Brain Injury.
NCT05747222
Efficacy of Rehabilitation Using Action Observation and Muscle Stimulation in Post-stroke Patients.
NCT06055569
Action Observation Training for Upper Limb Rehabilitation in Stroke Patients
NCT04622189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Aim of the Study: The main aim of the present study is to assess the efficacy of action observation treatment in the rehabilitation of upper limb motor functions in acute stroke patients and in chronic stroke patients with apraxia. The study will also aim at assessing neuroplasticity within areas belonging to the MNS through functional magnetic resonance (fMRI).
3. Study design: monocentric, randomized, controlled trial with 2 parallel arms: Action Observation Treatment (AOT) and Observation of videos with no motor content (Motorial Neutral Observation (MNO). By describing the study, we will follow the guidelines suggested in the CONSORT 2010 Statement
4. Clinical and functional evaluation: all assessments will be done by a neurologist and a physiotherapist not involved in the rehabilitation program and blinded with respect to patients' group assignment. The Fugl-Meyer, will be used for the motor assessment of the upper extremity (FMA, range 0-66) while the Functional Independence Measure (FIM, range 18 - 126) will be used for global functional evaluation. In order to investigate neurophysiological changes the Modified Ashworth Scale (MAS, range 0-5) as measure of spasticity in shoulder abductors, elbow, wrist, finger and thumb flexors will be administered. Also the Visual Analogue Scale (VAS, range 0 - 10) for pain assessment will be used. At the end of treatment, the subjects will provide a score of satisfaction with the therapy (1=poor; 2=sufficient; 3=good; 4=excellent). All patients will be assessed from a cognitive point of view with Mini Mental State Examination (MMSE). To check for the presence of apraxia, the scales of De Renzi and Goldenberg for ideational and ideomotor apraxia will be applied. In order to rule out aphasia, the Token Test and the test of free association between words will be used used. Working memory will be evaluated by means of verbal and visuospatial span. Depression of mood will be investigated in all patients through the Beck Depression Inventory.
This evaluation and testing will be applied to both acute stroke inpatients and chronic stroke outpatients referring to the Stroke Unit of Scientific Institute for Research and Treatment (IRCCS) Neuromed.
5. Study Population and recruitment: A total of 80 patients, including acute stroke patients and chronic stroke patients with apraxia, referred to the Stroke Unit of the clinical center will be recruited.
The research staff in charge of the recruitment will pre-screen participants on the basis of inclusion/exclusion criteria and will explain the study at this time.
If the subject is eligible for the study according to the inclusion/exclusion criteria, she/he will be included into the trial and randomised, using a computer-based random-number generator, to receive daily AOT or MNO. Before inclusion patients and controls will be asked to sign an informed consent.
During AOT or MNO, all patients will undergo conventional rehabilitation treatment, with the following activity: passive mobilization of paretic side, muscle recruitment of paretic side, induction of postural reaction.
6. Statistical analysis: before entering further analysis, scores obtained in the Fugl Meyer and FIM functional scales will enter Levene's test to assess homogeneity of variance in the two groups. Following this, a mixed-design analysis of variance (ANOVA), with time (T1, T2, T3, T4) as a within-participant factor and group (case, control) as a between-participants factor, will be carried out on the scores. To identify the source of significant differences among means, post-hoc analysis will be performed using the Newman Keuls test. The significance level for post-hoc comparisons will be set at 0.05. To further test the efficacy of treatment, functional score gain (D: score at T3 minus score at T2) will be calculated for each group and a planned t-test for independent samples performed.
7. Experimental protocol with Functional Magnetic Resonance (fMRI): an experimental paradigm similar to that used by Binkofski et al., 1999 will be used to assess activation of sensorimotor circuits related to grasping/manipulation actions before AOT and at the end of AOT treatment, with the aim to study re-organization within these circuits or to assess the recruitment of alternative areas/circuits following the treatment. Subjects will lay supine in the scanner with the head immobilized with a pneumatic cushion and the eyes open. The room will be dark. The subjects will be asked to manipulate continuously either five complexes objects or a sphere. Each object will be placed into the participant's hand at the beginning of an activation phase and removed at the end of it by one of the experimenters. As a control, participants will be asked to manipulate a sphere. Manipulation actions will include movements of all finger. Both hands will be tested, separately. The testing order will be randomized across subjects. A block design paradigm will be used with each block lasting 20 s. Neuroradiological images will be analyzed with MATLAB (Mathworks Inc., Natiek, MA, USA) and statistical parametric mapping package SPM96 (Friston et al., 1994a,b; 1995b, 1997; Poline et al., 1995; Worsley \& Friston, 1995).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Action Observation Treatment (AOT)
Conventional physiotherapy + Action Observation Treatment
Action Observation Treatment (AOT)
Participants will be asked to carefully observe at a computer screen videos depicting different daily actions. Each action will consist of 3 to 4 constituent motor acts. Each motor act will be presented for 3 minutes. As a whole, therefore, each video will be 12 minutes long. At the end of each motor act presentation, participants will be required to execute with the affected hand the observed motor sequence for 2 minutes. Each single rehabilitation session based on AOT will last 20 minutes. We will record ten daily actions for a total of ten video-clips. Participants will be presented with each video clips, twice a day, in order of complexity as judged by the experimenter. Participants will undergo 10 sessions a week, each lasting 20 minutes for 2 weeks.
Observation of videos with no motor content (MNO)
Conventional physiotherapy + Observation of videos with no motor content (MNO)
Observation of videos with no motor content (MNO)
Participants will be asked to observe video clips with no specific motor content. Videos will concern scientific, geographical and historical issues. As for cases, video clips will be divided into three to four parts. At the end of each part, controls will execute the same actions as cases, in the same order. In this way cases and controls will undergo the same amount of motor practice and receive the same amount of visual stimulation, the only difference being the content of visual stimuli.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Action Observation Treatment (AOT)
Participants will be asked to carefully observe at a computer screen videos depicting different daily actions. Each action will consist of 3 to 4 constituent motor acts. Each motor act will be presented for 3 minutes. As a whole, therefore, each video will be 12 minutes long. At the end of each motor act presentation, participants will be required to execute with the affected hand the observed motor sequence for 2 minutes. Each single rehabilitation session based on AOT will last 20 minutes. We will record ten daily actions for a total of ten video-clips. Participants will be presented with each video clips, twice a day, in order of complexity as judged by the experimenter. Participants will undergo 10 sessions a week, each lasting 20 minutes for 2 weeks.
Observation of videos with no motor content (MNO)
Participants will be asked to observe video clips with no specific motor content. Videos will concern scientific, geographical and historical issues. As for cases, video clips will be divided into three to four parts. At the end of each part, controls will execute the same actions as cases, in the same order. In this way cases and controls will undergo the same amount of motor practice and receive the same amount of visual stimulation, the only difference being the content of visual stimuli.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 18-85 years,
* Upper limb plegia or paresis with muscle strength in grasping Medical Research Council (MRC) \< 4,
* ability to understand and carry out simple verbal instruction,
* Mini Mental State Examination (MMSE) ≥ 20.
Exclusion Criteria
* severe psychiatric disorders,
* pre-existing rheumatic, orthopedic or muscular affection involving the upper limb,
* moderate to severe fluent aphasia,
* Neglect.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Neuromed IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giovanni Buccino
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giovanni Buccino, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Neuromed IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neuromed IRCCS, Istituto Neurologico Mediterraneo
Pozzilli, Isernia, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Borges LR, Fernandes AB, Oliveira Dos Passos J, Rego IAO, Campos TF. Action observation for upper limb rehabilitation after stroke. Cochrane Database Syst Rev. 2022 Aug 5;8(8):CD011887. doi: 10.1002/14651858.CD011887.pub3.
Related Links
Access external resources that provide additional context or updates about the study.
Click here for more information about this study: Cognitive recovery after stroke: Translational approach to new therapies of higher motor deficits (COGSTROKE). summary (pdf, 262 KB)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
neuromedbuccino01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.